GlassScriptPhysician profile
Douglas M Woseth
NPI 1619978970
$33,287.01
in general payments reported to CMS, 2019-2025
30 companies · $779 in 2025
The $779 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $679 · 2021: $766 · 2022: $12K · 2023: $17K · 2024: $803 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $2,435 · Travel and Lodging: $920 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,850.00 |
| Food and Beverage | $2,435.03 |
| Travel and Lodging | $919.81 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $28,044.49 | 2022-2024 | Opzelura |
| Abbvie INC. | $1,164.83 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Janssen Biotech, INC. | $654.75 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Pfizer INC. | $601.55 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $554.41 | 2019-2025 | |
| Ucb, INC. | $390.71 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $230.55 | 2019-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $194.57 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $190.45 | 2019-2025 | |
| Lilly USA, LLC | $183.34 | 2019-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $175.52 | 2021-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $150.19 | 2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $122.54 | 2019-2022 | |
| Dermavant Sciences, INC. | $91.27 | 2023-2024 | Vtama |
| Amgen INC. | $66.70 | 2022-2024 | Otezla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $63.42 | 2021-2023 | Dupixent |
| Genentech USA, INC. | $62.26 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $44.02 | 2020 | |
| Prugen, INC. Pharmaceuticals | $43.24 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $40.97 | 2022-2025 | Sotyktu |
| Organon LLC | $35.05 | 2025 | Vtama |
| Allergan, INC. | $33.88 | 2022 | |
| Botanix Sb INC | $31.89 | 2025 | Sofdra |
| Merz North America, INC. | $29.49 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $25.76 | 2019 | |
| Journey Medical Corporation | $25.74 | 2025 | |
| Biofrontera INC. | $19.00 | 2022 | |
| Epi Health, LLC | $16.42 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Woseth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.